3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine
![]() |
- $45 - $5317
- Product name: 3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine
- CAS: 1305324-61-1
- MF: C6H3BrIN3
- MW: 323.92
- EINECS:
- MDL Number:MFCD20487040
- Synonyms:3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine;1H-Pyrazolo[3,4-b]pyridine, 3-bromo-5-iodo-;3-Bromo-5-iodo-2H-pyrazolo[3,4-b]pyridine
5 prices
Selected condition:
Brand
- Crysdot
- Labseeker
- Matrix Scientific
- TRC
Package
- 10mg
- 100mg
- 250mg
- 1g
- 25g
- ManufacturerCrysdot
- Product numberCD11297775
- Product description3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine 95+%
- Packaging1g
- Price$904
- Updated2021-12-16
- Buy
- ManufacturerLabseeker
- Product numberSC-48918
- Product description3-bromo-5-iodo-1H-Pyrazolo[3,4-b]pyridine, 95
- Packaging25g
- Price$5317
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number070909
- Product description3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine
- Packaging250mg
- Price$461
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB703315
- Product description3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine
- Packaging10mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB703315
- Product description3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine
- Packaging100mg
- Price$240
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11297775 | 3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine 95+% | 1g | $904 | 2021-12-16 | Buy |
Labseeker | SC-48918 | 3-bromo-5-iodo-1H-Pyrazolo[3,4-b]pyridine, 95 | 25g | $5317 | 2021-12-16 | Buy |
Matrix Scientific | 070909 | 3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine | 250mg | $461 | 2021-12-16 | Buy |
TRC | B703315 | 3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine | 10mg | $45 | 2021-12-16 | Buy |
TRC | B703315 | 3-Bromo-5-iodo-1H-pyrazolo[3,4-b]pyridine | 100mg | $240 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|